+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Benzodiazepine"

General Anxiety Disorder (GAD) - Pipeline Insight, 2025 - Product Thumbnail Image

General Anxiety Disorder (GAD) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
From
From
Sleep Disorder Treatment Market - Forecasts from 2023 to 2028 - Product Thumbnail Image

Sleep Disorder Treatment Market - Forecasts from 2023 to 2028

  • Report
  • December 2023
  • 140 Pages
  • Global
From
From
Psychotropic Drug Market in India - Product Thumbnail Image

Psychotropic Drug Market in India

  • Report
  • January 2026
  • 150 Pages
  • India
From
Psychotropic Drug Market in Germany - Product Thumbnail Image

Psychotropic Drug Market in Germany

  • Report
  • October 2025
  • 150 Pages
  • Germany
From
From
From
Loading Indicator

Benzodiazepines are a class of psychoactive drugs used to treat mental disorders such as anxiety, insomnia, and seizures. They act on the central nervous system to produce a calming effect, and are often prescribed to treat symptoms of anxiety, panic, and insomnia. Benzodiazepines are also used to treat alcohol withdrawal, muscle spasms, and seizures. They are generally considered to be safe and effective when used as prescribed, but can be habit-forming and have the potential for abuse. Benzodiazepines are among the most commonly prescribed drugs in the world, and are widely used to treat a variety of mental health conditions. They are generally considered to be safe and effective when used as prescribed, but can be habit-forming and have the potential for abuse. Some companies in the benzodiazepine market include Pfizer, GlaxoSmithKline, Sanofi, and Mylan. Show Less Read more